{
    "id": 10163,
    "fullName": "NOTCH1 C478F",
    "impact": "missense",
    "proteinEffect": "loss of function - predicted",
    "geneVariantDescriptions": [
        {
            "description": "NOTCH1 C478F lies within the calcium-binding EGF-like domain 12 of the Notch1 protein (UniProt.org). C478F is predicted to confer a loss of function to the Notch1 protein, as demonstrated by a loss of Notch1 reporter gene activation in cell culture (PMID: 24277854).",
            "references": [
                {
                    "id": 3402,
                    "pubMedId": 24277854,
                    "title": "Targeting Wnt-driven cancer through the inhibition of Porcupine by LGK974.",
                    "url": "http://www.ncbi.nlm.nih.gov/pubmed/24277854"
                }
            ]
        }
    ],
    "type": null,
    "gene": {
        "id": 4851,
        "geneSymbol": "NOTCH1",
        "terms": [
            "NOTCH1",
            "AOS5",
            "AOVD1",
            "hN1",
            "TAN1"
        ]
    },
    "variant": "C478F",
    "createDate": "08/05/2015",
    "updateDate": "08/13/2019",
    "referenceTranscriptCoordinates": {
        "id": 143269,
        "transcript": "NM_017617",
        "gDna": "chr9:g.136517760C>A",
        "cDna": "c.1433G>T",
        "protein": "p.C478F",
        "sourceDb": "RefSeq",
        "refGenomeBuild": "GRCh38/hg38"
    },
    "partnerGenes": [
        
    ],
    "evidence": [
        {
            "id": 19408,
            "approvalStatus": "Preclinical - Cell line xenograft",
            "evidenceType": "Actionable",
            "efficacyEvidence": "In a preclinical study, a head and neck squamous cell carcinoma cell line harboring NOTCH1 C478F demonstrated apoptotic activity and reduced colony growth in culture and tumor regression in cell line xenograft models when treated with GSK2126458 (PMID: 30770351).",
            "molecularProfile": {
                "id": 10166,
                "profileName": "NOTCH1 C478F"
            },
            "therapy": {
                "id": 763,
                "therapyName": "GSK2126458",
                "synonyms": null
            },
            "indication": {
                "id": 5520,
                "name": "head and neck squamous cell carcinoma",
                "source": "DOID"
            },
            "responseType": "predicted - sensitive",
            "references": [
                {
                    "id": 16991,
                    "pubMedId": 30770351,
                    "title": "PDK1 Mediates NOTCH1-Mutated Head and Neck Squamous Carcinoma Vulnerability to Therapeutic PI3K/mTOR Inhibition.",
                    "url": "http://www.ncbi.nlm.nih.gov/pubmed/30770351"
                }
            ],
            "ampCapAscoEvidenceLevel": "D",
            "ampCapAscoInferredTier": "II"
        },
        {
            "id": 19417,
            "approvalStatus": "Preclinical - Cell line xenograft",
            "evidenceType": "Actionable",
            "efficacyEvidence": "In a preclinical study, head and neck squamous cell carcinoma xenograft models harboring NOTCH1 C478F demonstrated reduced tumor size when treated with PQR309 (bimiralisib) (PMID: 30770351).",
            "molecularProfile": {
                "id": 10166,
                "profileName": "NOTCH1 C478F"
            },
            "therapy": {
                "id": 2019,
                "therapyName": "PQR309",
                "synonyms": null
            },
            "indication": {
                "id": 5520,
                "name": "head and neck squamous cell carcinoma",
                "source": "DOID"
            },
            "responseType": "predicted - sensitive",
            "references": [
                {
                    "id": 16991,
                    "pubMedId": 30770351,
                    "title": "PDK1 Mediates NOTCH1-Mutated Head and Neck Squamous Carcinoma Vulnerability to Therapeutic PI3K/mTOR Inhibition.",
                    "url": "http://www.ncbi.nlm.nih.gov/pubmed/30770351"
                }
            ],
            "ampCapAscoEvidenceLevel": "D",
            "ampCapAscoInferredTier": "II"
        },
        {
            "id": 2689,
            "approvalStatus": "Preclinical",
            "evidenceType": "Actionable",
            "efficacyEvidence": "In a preclinical study, LGK974 inhibited growth of head and neck squamous cell carcinoma cells harboring NOTCH1 C478F in culture and xenograft models (PMID: 24277854).",
            "molecularProfile": {
                "id": 10166,
                "profileName": "NOTCH1 C478F"
            },
            "therapy": {
                "id": 1937,
                "therapyName": "LGK974",
                "synonyms": null
            },
            "indication": {
                "id": 5520,
                "name": "head and neck squamous cell carcinoma",
                "source": "DOID"
            },
            "responseType": "sensitive",
            "references": [
                {
                    "id": 3402,
                    "pubMedId": 24277854,
                    "title": "Targeting Wnt-driven cancer through the inhibition of Porcupine by LGK974.",
                    "url": "http://www.ncbi.nlm.nih.gov/pubmed/24277854"
                }
            ],
            "ampCapAscoEvidenceLevel": "D",
            "ampCapAscoInferredTier": "II"
        },
        {
            "id": 19418,
            "approvalStatus": "Preclinical - Cell culture",
            "evidenceType": "Actionable",
            "efficacyEvidence": "In a preclinical study, head and neck squamous cell carcinoma cells harboring NOTCH1 C478F and overexpressing PDK1 demonstrated a decrease in apoptotic activity compared to the cells not overexpressing PDK1 when treated with GSK2126458 (PMID: 30770351).",
            "molecularProfile": {
                "id": 34089,
                "profileName": "NOTCH1 C478F PDK1 over exp"
            },
            "therapy": {
                "id": 763,
                "therapyName": "GSK2126458",
                "synonyms": null
            },
            "indication": {
                "id": 5520,
                "name": "head and neck squamous cell carcinoma",
                "source": "DOID"
            },
            "responseType": "decreased response",
            "references": [
                {
                    "id": 16991,
                    "pubMedId": 30770351,
                    "title": "PDK1 Mediates NOTCH1-Mutated Head and Neck Squamous Carcinoma Vulnerability to Therapeutic PI3K/mTOR Inhibition.",
                    "url": "http://www.ncbi.nlm.nih.gov/pubmed/30770351"
                }
            ],
            "ampCapAscoEvidenceLevel": "NA",
            "ampCapAscoInferredTier": "NA"
        }
    ],
    "molecularProfiles": [
        {
            "id": 10166,
            "profileName": "NOTCH1 C478F",
            "profileTreatmentApproaches": [
                
            ]
        },
        {
            "id": 34089,
            "profileName": "NOTCH1 C478F PDK1 over exp",
            "profileTreatmentApproaches": [
                
            ]
        }
    ],
    "allTranscriptCoordinates": [
        {
            "id": 143269,
            "transcript": "NM_017617",
            "gDna": "chr9:g.136517760C>A",
            "cDna": "c.1433G>T",
            "protein": "p.C478F",
            "sourceDb": "RefSeq",
            "refGenomeBuild": "GRCh38/hg38"
        }
    ]
}